Safety and efficacy of 4aminopyridine in humans with spinal cord injury: a long-term, controlled trial. Pharmacotherapy 19: 713
1999 · 0 citations
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
1.3K
Citations
20
h-index
35
i10-index
Jack L. Segal is an academic researcher from The Lundquist Institute. The author has contributed to research in topics: Spinal Cord Injury Research & Antibiotics Pharmacokinetics and Efficacy & Epilepsy research and treatment. The author has an h-index of 20, co-authored 48 publications.
Click to start Chat